Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$440,000 |
 |
Johnson & JohnsonJNJ |
-$120M |
 |
Mind Medicine (MindMed)MNMD |
-$86M |
 |
ModernaMRNA |
-$37.4B |
 |
AbbVieABBV |
-$792M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Ugwumba Chidozie | Jan 23, 2026 | Sell | 5,556 | $5.27 | $29,000 |
| Ugwumba Chidozie | Jan 22, 2026 | Sell | 12,665 | $5.32 | $67,000 |
| Ugwumba Chidozie | Jan 21, 2026 | Sell | 12,119 | $5.05 | $61,000 |
| Ugwumba Chidozie | Jan 20, 2026 | Sell | 12,432 | $4.8 | $60,000 |
| Ugwumba Chidozie | Jan 16, 2026 | Sell | 7,923 | $5.13 | $41,000 |
| Ugwumba Chidozie | Jan 15, 2026 | Sell | 12,563 | $5.1 | $64,000 |
| Ugwumba Chidozie | Jan 14, 2026 | Sell | 19,621 | $5.12 | $100,000 |
| Ugwumba Chidozie | Jan 13, 2026 | Sell | 26,105 | $4.89 | $130,000 |
| MATLIN DAVID J | Jan 13, 2026 | Buy | 33,333 | $6.5 | $220,000 |
| Ugwumba Chidozie | Jan 12, 2026 | Sell | 32,705 | $5.5 | $180,000 |
| Ugwumba Chidozie | Jan 9, 2026 | Sell | 9,075 | $6.27 | $57,000 |
| Ugwumba Chidozie | Jan 8, 2026 | Sell | 3,195 | $6.09 | $19,000 |
| Ugwumba Chidozie | Jan 7, 2026 | Sell | 3,938 | $6.29 | $25,000 |
| Ugwumba Chidozie | Jan 6, 2026 | Sell | 3,111 | $6.04 | $19,000 |
| Ugwumba Chidozie | Jan 5, 2026 | Sell | 5,869 | $5.87 | $34,000 |
| Ugwumba Chidozie | Jan 2, 2026 | Sell | 4,015 | $5.73 | $23,000 |
| Ugwumba Chidozie | Dec 31, 2025 | Sell | 13,095 | $5.81 | $76,000 |
| Ugwumba Chidozie | Dec 30, 2025 | Sell | 4,138 | $6.03 | $25,000 |
| Ugwumba Chidozie | Dec 29, 2025 | Sell | 8,096 | $5.95 | $48,000 |
| Ugwumba Chidozie | Dec 26, 2025 | Sell | 3,350 | $6.32 | $21,000 |
| Ugwumba Chidozie | Dec 24, 2025 | Sell | 1,490 | $6.27 | $9,300 |
| Ugwumba Chidozie | Dec 23, 2025 | Sell | 6,831 | $6.27 | $43,000 |
| Ugwumba Chidozie | Dec 22, 2025 | Sell | 4,367 | $6.54 | $29,000 |
| Ugwumba Chidozie | Dec 19, 2025 | Sell | 5,582 | $6.45 | $36,000 |
| Ugwumba Chidozie | Dec 18, 2025 | Sell | 5,816 | $6.33 | $37,000 |
| Ugwumba Chidozie | Dec 17, 2025 | Sell | 2,884 | $6.61 | $19,000 |
| Ugwumba Chidozie | Dec 16, 2025 | Sell | 7,030 | $6.31 | $44,000 |
| Ugwumba Chidozie | Dec 15, 2025 | Sell | 10,580 | $6.49 | $69,000 |
| Ugwumba Chidozie | Dec 12, 2025 | Sell | 7,603 | $6.79 | $52,000 |
| Ugwumba Chidozie | Dec 11, 2025 | Sell | 10,907 | $6.81 | $74,000 |
| Ugwumba Chidozie | Dec 10, 2025 | Sell | 9,921 | $6.42 | $64,000 |
| Ugwumba Chidozie | Dec 9, 2025 | Sell | 15,031 | $5.95 | $89,000 |
| Ugwumba Chidozie | Dec 8, 2025 | Sell | 21,463 | $5.7 | $120,000 |
| Ugwumba Chidozie | Dec 5, 2025 | Sell | 37,235 | $5.94 | $220,000 |
| Ugwumba Chidozie | Dec 4, 2025 | Sell | 72,748 | $6.73 | $490,000 |
| Ugwumba Chidozie | Dec 3, 2025 | Sell | 56,577 | $7.86 | $440,000 |
| General Resonance LLC | Aug 21, 2025 | Sell | 3,401 | $5.34 | $18,000 |
| General Resonance LLC | Jun 4, 2025 | Sell | 600 | $4.04 | $2,400 |
| General Resonance LLC | Jun 2, 2025 | Sell | 600 | $4.121 | $2,500 |
| General Resonance LLC | May 30, 2025 | Sell | 410 | $2.8 | $1,100 |
| General Resonance LLC | May 29, 2025 | Sell | 410 | $2.73 | $1,100 |
| General Resonance LLC | May 28, 2025 | Sell | 420 | $2.595 | $1,100 |
| General Resonance LLC | May 27, 2025 | Sell | 420 | $2.45 | $1,000 |
| General Resonance LLC | Mar 19, 2025 | Sell | 1,400 | $4.4 | $6,200 |
| General Resonance LLC | Mar 18, 2025 | Sell | 1,333 | $4.45 | $5,900 |
| MATLIN DAVID J | Sep 30, 2024 | Buy | 92,307 | $4.75 | $440,000 |
| Mortenson Mark | Sep 30, 2024 | Buy | 20,512 | $4.75 | $97,000 |
| Etherington Robert Dee | Sep 30, 2024 | Buy | 10,000 | $4.75 | $48,000 |
| General Resonance LLC | May 1, 2024 | Sell | 13,000 | $0.396 | $5,100 |
| General Resonance LLC | Apr 24, 2024 | Sell | 10,000 | $0.3278 | $3,300 |
| General Resonance LLC | Apr 9, 2024 | Sell | 7,500 | $0.3831 | $2,900 |
FAQ - Insider Transactions
The most recent insider transaction for Clene was conducted by Ugwumba Chidozie, who sold 5,556 shares on January 23, 2026 at a price of $5.27 per share.
MATLIN DAVID J has bought the most CLNN stock in the last 2 years, with a total value of $660,000.
Ugwumba Chidozie has sold the most CLNN stock in the last 2 years, with a total value of $2.9M.
The total value of insider transactions for Clene in the last 2 years is negative, amounting to -$2.2M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Clene have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
